{'fraction_non_alphanumeric': 0.024745269286754003, 'fraction_numerical': 0.005822416302765648, 'mean_word_length': 5.490566037735849, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Part I: Inflammatory bowel disease

LEARNING OBJECTIVES 1. Apply results from clinical studies and guidelines to the management of inflammatory bowel disease (IBD) (Crohn disease and ulcerative colitis). 2. Design evidence-based treatment regimens for patients with IBD. 3. According to clinical studies, medication cost, and current guidelines, justify the appropriateness of using biosimilars and other medications in the treatment of IBD. 4. Assess and apply the results from clinical studies focused on therapeutic drug monitoring in providing appropriate treatment recommendations and medication education to patients and health care providers in the treatment of patients with IBD.